GFP-BRD4 Citations (5)
Originally described in: Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.Gong F, Chiu LY, Cox B, Aymard F, Clouaire T, Leung JW, Cammarata M, Perez M, Agarwal P, Brodbelt JS, Legube G, Miller KM Genes Dev. 2015 Jan 15;29(2):197-211. doi: 10.1101/gad.252189.114. PubMed Journal
Articles Citing GFP-BRD4
Articles |
---|
Optical Control of Small Molecule-Induced Protein Degradation. Naro Y, Darrah K, Deiters A. J Am Chem Soc. 2020 Feb 5;142(5):2193-2197. doi: 10.1021/jacs.9b12718. Epub 2020 Jan 23. PubMed |
Enhanced transcriptional heterogeneity mediated by NF-kappaB super-enhancers. Wibisana JN, Inaba T, Shinohara H, Yumoto N, Hayashi T, Umeda M, Ebisawa M, Nikaido I, Sako Y, Okada M. PLoS Genet. 2022 Jun 1;18(6):e1010235. doi: 10.1371/journal.pgen.1010235. eCollection 2022 Jun. PubMed |
Engineered PROTAC-CID Systems for Mammalian Inducible Gene Regulation.
Ma D, Yuan Q, Peng F, Paredes V, Zeng H, Osikpa EC, Yang Q, Peddi A, Patel A, Liu MS, Sun Z, Gao X.
J Am Chem Soc. 2023 Jan 25;145(3):1593-1606. doi: 10.1021/jacs.2c09129. Epub 2023 Jan 10.
PubMed
Associated Plasmids |
Repetitive CREB-DNA interactions at gene loci predetermined by CBP induce activity-dependent gene expression in human cortical neurons. Atsumi Y, Iwata R, Kimura H, Vanderhaeghen P, Yamamoto N, Sugo N. Cell Rep. 2024 Jan 23;43(1):113576. doi: 10.1016/j.celrep.2023.113576. Epub 2023 Dec 20. PubMed |
DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia. Ali I, Cha HJ, Lim B, Chae CH, Youm J, Park WJ, Lee SH, Kim JH, Jeong D, Lim JK, Hwang YH, Roe JS, Woo JS, Lee K, Choi G. Eur J Med Chem. 2024 Feb 5;265:116052. doi: 10.1016/j.ejmech.2023.116052. Epub 2023 Dec 16. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.